4월 17일(금) |
- 제 2회의장 - |
08:30~10:00 Interesting ECG |
: 김영훈, 신동구 |
Panel: 김준, 김진배, 남궁준, 신대희, 임홍의, 현대우 |
10:30~12:30 Catheter Ablation Technology |
: 최윤식, 조정관 |
10:30-10:55 |
1. RF Energy Monitoring During Ablation |
오세일/서울의대 |
10:55-11:20 |
2. New Energy Sources and Catheters for Ablation
|
최기준/울산의대 |
11:20-11:45 |
3. New Approaches to Unusual Targets |
박희남/연세의대 |
11:45-12:10 |
4. Image Integration & Catheter Navigation Technology
|
오용석/가톨릭의대 |
12:10-12:30 |
5. Panel Discussion |
Panel: 이만영, 이문형 |
14:00~16:00 Update in Interventional Cardiology |
: 심원흠, 김영조 |
14:00-14:20 |
1. Immediate Beta Blockade in STEMI Patients : Is It Really Helpful?
|
김 원/경희의대 |
14:20-14:40 |
2. Immediate Statin in STEMI Patients : Is It Really Helpful?
|
박종선/영남의대 |
14:40-15:00 |
3. Contrast-Induced Nephropathy, Prognostic Implication & Prevention; Current Status
|
조상호/한림의대 |
15:00-15:20 |
4. Plavix Resistance, Cause & Clinical Implication: Current Status
|
서정원/서울의대 |
15:20-15:40 |
5. Recent Clinical Data of 3rd Generation DES
|
배장호/건양의대 |
15:40-16:00 |
6. Panel Discussion |
|
Panel: 김무현, 김종진, 김효수, 박성욱, 성인환, 안영근, 안태훈, 장양수 |
16:30~18:30 Debate in Interventional Cardiology |
: 신익균, 김권배 |
In certain patients with Stable Angina |
16:30-16:42 |
1. Medical Treatment is Better
|
이철환/울산의대 |
16:42-16:54 |
2. PCI is Better
|
김명곤/경희의대 |
16:54-17:00 |
3. Panel Discussion |
Panel: 양주영, 연태진, 최동훈 |
In Certain Patients with Multi-vessel Disease |
17:00-17:12 |
1. CABG is Better
|
배장환/충북의대 |
17:12-17:24 |
2. PCI is Better
|
현민수/순천향의대 |
17:24-17:30 |
3. Panel Discussion |
Panel: 김영대, 승기배, 전동운 |
In Certain Patients with Left Main Disease |
17:30-17:42 |
1. CABG is Better
|
김기봉/서울의대 |
17:42-17:54 |
2. PCI is Better
|
홍명기/연세의대 |
17:54-18:00 |
3. Panel Discussion |
Panel: 김병극, 나승운, 박금수 |
In Certain Patients with CTO |
18:00-18:12 |
1. Medical is Better
|
김영학/울산의대 |
18:12-18:24 |
2. Revascularization is Better
|
이내희/순천향의대 |
18:24-18:30 |
3. Panel Discussion |
Panel: 박헌식, 이재환, 정명호 |
- 제 4회의장 - |
08:30~10:00 Controversies in Pediatric Heart Disease |
: 노정일, 이주원 |
08:30-08:50 |
1. Adult Congenital Heart Disease
|
허준/성균관의대 |
08:50-09:10 |
2. Screening for Sudden Death in Childhood and Adolescents
|
김남수/한양의대 |
09:10-09:30 |
3. Obseity and Heart Disease in Childhood and Adolescents
|
홍영미/이화의대 |
09:30-09:50 |
4. Medical Treatment in Myocarditis and Cardiomyopathy
|
김여향/계명의대 |
09:50-10:00 |
5. Panel Discussion |
Panel: 송영환, 이동석, 진선미 |
10:30~12:30 Recent Advance in Fetal Cardiology |
: 이흥재, 성시찬 |
10:30-10:50 |
1. The Role of the Fetal Cardiologist in Non-cardiac Fetal Conditions
|
윤신원/중앙의대 |
10:50-11:10 |
2. Heart Failure in the Fetus
|
송민섭/인제의대 |
11:10-11:30 |
3. Fetal Cardiovascular Physiology: Characterization by Echocardiography |
정조원/아주의대 |
11:30-11:50 |
4. Current Status of Fetal Surgical Intervention
|
이정렬/서울의대 |
11:50-12:10 |
5. Organizing a Comprehensive Fetal Cardiology Program
|
원혜성/울산의대 |
12:10-12:30 |
6. Panel Discussion |
Panel: 강수정, 박정준, 은영민 |
14:00~16:00 Recent Advance in Pediatric CHF |
: 오봉석, 이상범 |
14:00-14:20 |
1. Diagnosis and Classification
|
최재영/연세의대 |
14:20-14:40 |
2. Medical Management
|
김수진/부천세종병원 |
14:40-15:00 |
3. Electrophysiology Management : Biventricular Pacing and ICD
|
현명철/경북의대 |
15:00-15:20 |
4. Mechanical Circulatory Support
|
김시호/동아의대 |
15:20-15:40 |
5. Surgical Strategies for the Failing Systemic Ventricle
|
윤태진/울산의대 |
15:40-16:00 |
6. Panel Discussion |
Panel: 양지혁, 우향옥, 반지은 |
16:30-18:30 Advance in Pediatric Cardiac Surgery |
: 김용진, 이광숙 |
16:30-16:50 |
1. Current Strategy for RVOT Reconstruction
|
박한기/연세의대 |
16:50-17:10 |
2. Strategy for Improving Neurologic OutcomeAfter Congenital Cardiac Surgery
|
박정준/울산의대 |
17:10-17:30 |
3. Neonatal Repair vs. Staged Repair in Pulmonary Atresia with VSD
|
양지혁/성균관의대 |
17:30-17:50 |
4. Arrhythmia Surgery in Single Ventricle
|
김웅한/서울의대 |
17:50-18:10 |
5. Modifications of Fontan Procedure to Reduce Pulmonary Arteriovenous Malformations
|
임홍국/부천세종병원 |
18:10-18:30 |
6. Panel Discussion |
Panel: 박영환, 서동만, 성시찬 |
4월 18일(토) |
- 제 1회의장 - |
08:30~10:00 Advance in Interventional Technology and Device 1 |
: 조승연, 박승정 |
08:30-08:45 |
1. OCT
|
조진만/경희의대 |
08:45-09:00 |
2. Cardiac MRI |
이 상/을지의대 |
09:00-09:15 |
3. Myocardial CT Imaging
|
김윤현/전남의대 |
09:15-09:30 |
4. IVUS & VH
|
고영엽/조선의대 |
09:30-09:45 |
5. FFR & CFR
|
윤명호/아주의대 |
09:45-10:00 |
6. Panel Discussion |
|
Panel: 구본권, 윤정한, 이상훈, 채제건, 최영진, 최진호, 탁승제, 홍영준, 홍택종 |
10:30~12:00 Advance in Interventional Technology and Device 2 |
: 박영배, 이상훈 |
10:30-10:45 |
1. Myocardial Salvage in AMI-Preconditioning, Postconditioning
|
김두일/인제의대 |
10:45-11:00 |
2. PCPS
|
한주용/성균관의대 |
11:00-11:15 |
3. EVAR (AAA and Aortic Dissection)
|
고영국/연세의대 |
11:15-11:30 |
4. Drug Eluting Balloon |
박경우/서울의대 |
11:30-11:45 |
5. Next Generation DES
|
이준희/한림의대 |
11:45-12:00 |
6. Panel Discussion |
|
Panel: 권현철, 이상곤, 이승환, 조영석, 정욱성, 차광수, 최승혁, 한규록, 허승호 |
12:00~12:40 서순규 교수 기념특강 |
: 심봉섭 |
12:00-12:40 |
Molecular Control of Vascular Development |
Anne Eichmann/College de France, France |
14:00-16:00 Hypertension in Medtabolic Syndrome |
: 홍순표, 김철호 |
14:00-14:20 |
1. Epidemiologic and Physiologic Relevance of Surrogate Markers for CV Events
|
최승혁/성균관의대 |
14:20-14:40 |
2. Inflammation in Hypertension and Metabolic Syndrome
|
김응주/고려의대 |
14:40-15:00 |
3. Aging or Insulin Resistance in Hypertension and Metabolic Syndrome
|
김광일/서울의대 |
15:00-15:20 |
4. How to Stop the Progression of Metabolic Syndrome to CV Events
|
이무용/동국의대 |
15:40-16:00 |
5. Panel Discussion |
Panel: 고광곤, 김영권, 박창규, 성기철, 차봉수 |
- 제 2회의장 - |
08:30-10:00 Novel Targets in AF Management |
: 김성순, 오동진 |
08:30-08:50 |
1. Pathophysiology of AF
|
남기병/울산의대 |
08:50-09:10 |
2. Pharmacological Therapy for Substrate Modification
|
곽충환/경상의대 |
09:10-09:30 |
3. New Antithrombotic Drugs
|
이명용/단국의대 |
09:30-09:50 |
4. New Antiarrhythmic Drugs
|
박경민/인제의대 |
09:50-10:00 |
5. Panel Discussion |
Panel: 김대경, 김진석, 정병천 |
10:30-12:00 Sudden Cardiac Death |
: 노태호, 최인석 |
10:30-10:50 |
1. Noninvasive Assessment of SCD Risk in Patients with Structural Heart Disease
|
신동구/영남의대 |
10:50-11:10 |
2. Role of EPS in the Evaluation of High-Risk Patients for SCD
|
차태준/고신의대 |
11:10-11:30 |
3. Management of Channelopathy Including LQTS and Brugada Syndrome
|
조용근/경북의대 |
11:30-11:50 |
4. ICD for Primary Prevention
|
김남호/원광의대 |
11:50-12:00 |
5. Panel Discussion |
Panel: 김준수, 이영수, 정중화 |
14:00-16:00 CRT |
: 김유호, 김윤년 |
14:00-14:20 |
1. Evaluation of Dyssynchrony |
조구영/서울의대 |
14:20-14:40 |
2. Role of CT and MRI for CRT Candidates |
이상철/성균관의대 |
14:40-15:00 |
3. Predictors of CRT Response
|
박형욱/전남의대 |
15:00-15:20 |
4. Current & Emerging Indications of CRT
|
이경석/전북의대 |
15:20-15:40 |
5. Technical Aspects of CRT Device Implantation
|
박상원/고려의대 |
15:40-16:00 |
6. Panel Discussion |
Panel: 조용근, 황교승 |
- 제 3회의장 -
|
08:30~10:00 Evaluation of Atherosclerosis |
: 신현호, 김치정 |
08:30-08:50 |
1. Gene and Atherosclerosis
|
박현영/국립보건원 |
08:50-09:10 |
2. Biomarker of Atherosclerosis
|
오석규/원광의대 |
09:10-09:30 |
3. Imaging of Atherosclerosis
|
김용진/서울의대 |
09:30-09:50 |
4. Primary Prevention of Atherosclerosis
|
한기훈/울산의대 |
09:50-10:00 |
5. Panel Discussion |
Panel: 김장영, 서홍석, 성지동, 김상현, 한승환 |
10:30~12:00 New Insigt for PPAR Agonist : Good and Bad Aspect |
: 박정의, 류왕성 |
10:30-10:50 |
1. PPARγ Agonists and Diabetes Control
|
우정택/경희의대 |
10:50-11:10 |
2. PPARγ Regulates Insulin Sensitivity and Atherosclerosis |
박경수/서울의대 |
11:10-11:30 |
3. PPARγ Agonists and CV Mortality
|
홍순준/고려의대 |
11:30-11:50 |
4. PPARδ Agonist and Vasculogenesis
|
한정규/서울의대 |
11:50-12:00 |
5. Panel Discussion |
Panel: 이문규, 임수, 차봉수, 한기훈, 황진용 |
14:00~16:00 Stem Cell Biology Review |
: 전은석, 김효수 |
14:00-14:25 |
1. Induced Pluripotent Stem Cells; Review of Current Status
|
조현재/서울의대 |
14:25-14:50 |
2. Vasculogenic Progenitor Cells; Review of Current Status
|
정형민/차바이오텍 |
15:50-15:15 |
3. Hematopoietic Stem Cells ; Review of the Current Status
|
엄현석/국립암센터 |
15:15-15:40 |
4. Cardiomyogenic & Adipose Stem Cells ; Review of the Current Status |
백상홍/카톨릭의대 |
15:40-16:00 |
5. Panel Discussion |
Panel: 강현재, 김경수, 안영근, 임도선 |
- 제 4회의장 -
|
08:30-10:00 Heart Failure with Preserved Ejection Fraction |
: 오병희, 조명찬 |
08:30-08:55 |
1. Clinical Implication and Pathophysiology
|
김동운/충북의대 |
08:55-09:20 |
2. How to Make a Diagnosis
|
박대균/한림의대 |
09:20-09:45 |
3. Which Drug is Choice of Treatment
|
김형섭/계명의대 |
09:45-10:00 |
4. Panel Discussion |
Panel: 김동수, 김영권, 백상홍, 정욱진 |
10:30-12:00 Heart Failure with Co-Morbidities |
: 이명묵, 유규형 |
10:30-10:50 |
1. Obesity in Heart Failure
|
강석민/연세의대 |
10:50-11:10 |
2. Diabetes in Heart Failure
|
주승재/제주의대 |
11:10-11:30 |
3. Inflammatory Cytokines in Heart Failure
|
한성우/건국의대 |
11:30-11:50 |
4. Nutrition in Heart Failure
|
신민정/고려대학교 |
11:50-12:00 |
5. Panel Discussion |
Panel: 김명아, 박재형, 전은석, 조명찬, 최동주 |
14:00~16:00 Multimodality Imaging for the 'Viability' |
: 임태환, 손대원 |
14:00-14:20 |
1. Viability : Clinical Significance |
박승우/성균관의대 |
14:20-14:40 |
2. SPECT
|
강원준/연세의대 |
14:40-15:00 |
3. CT
|
박은아/서울의대 |
15:00-15:20 |
4. Echo
|
송종민/울산의대 |
15:20-15:40 |
5. MRI
|
정정임/가톨릭의대 |
15:40-16:00 |
6. Panel Discussion |
Panel: 장혁재, 용환석, 이종민 |
* Satellite Symposium
|
4월 17일(금)
|
- 제 1회의장 -
|
GSK - The Latest Vasodilating Beta Blocker : From Hypertension to Heart Failure |
: 조승연, 이명묵 |
|
Action Mechanisms of Nebivolol; Nitric Oxide-releasing and Vasodilating
|
김효수/서울의대 |
|
Role of Beta Blocker in Elderly Heart Failure
|
전은석/성균관의대 |
- 제 2회의장 -
|
Sanofi-aventis - New Perspectives in the Management of Cardiovascular Diseases |
: 오병희, 장양수 |
|
RAS Blockade on Atrial Fibrillation; A Dream?
|
박정배/관동의대 |
|
The Role of Antiplatelet Therapy in the Era of Drug Eluting Stents |
Cindy L. Grines/Beaumont Hospital, USA |
- 제 3회의장 -
|
중외제약 - New Concept of Metabolic Syndrome and Beyond with Statin |
: 김덕경, 정명호 |
|
Chiba Study |
Kohji Shirai/School of Medicine Toho Univ., Japan |
|
급성 심근경색증 환자에서 Statin 사용으로 저밀도 지단백 콜레스테롤 목표치에의 도달과 예후와의 관계
|
홍영준/전남의대 |
|
Safety and Efficacy of Statin in Patients with Acute Myocardial Infarction in an Asian Population
|
나승운/고려의대 |
- 제 4회의장 -
|
한독약품 - Early Action in Pulmonary Arterial Hypertension |
: 정남식, 손대원 |
|
폐고혈압의 분류와 진단 및 평가
|
장혁재/연세의대 |
|
The Future of Pulmonary Arterial Hypertension (PAH) Management -Building on the Evidence |
Nazzareno Galie/Univ. of Bolona, Italy |
4월 18일(토)
|
- 제 1회의장 -
|
Boehringer Ingelheim & GSK- A New Era of Cardio & Vascular Protection Treatment with High Risk Patients |
: 김재형, 오동주 |
|
New Evidences in 24hr Blood Pressure Lowering Effect of Telmisartan in Comparative Trials
|
채성철/경북의대 |
|
ONTARGET : Asian Tolerability
|
서홍석/고려의대 |
- 제 2회의장 -
|
한국다이이찌산쿄/대웅제약 - Optimizing Synergistic Effect of CCB/ARB Combination Therapy |
: 박영배, 정명호 |
|
How to Manage Hypertensive Patients Who Fail to Achieve BP Goal?
|
김효수/서울의대 |
|
Combined Therapy with CCB and ARB: A New Combination Treatment Option to Better Control Hypertension |
Franz Messerli/St. Lukes-Roosevelt Hospital Center, USA |
- 제 3회의장 -
|
Merck Serono - Cardiovascular Diseases: Where Highly β-1 Selective Blockers Must be Used |
: 유규형, 승기배 |
|
Clinical Benefits of β-blockers in Hypertension & Heart Failure
|
최동주/서울의대 |
|
Proven Benefits of β-blockers in Ischemic Heart Disease
|
이철환/울산의대 |
- 제 4회의장 -
|
한국MSD - New Management of Cardiometabolic Disease |
: 이원로, 박정의 |
|
A New Paradigm in the Treatment of Type 2 Diabetes
|
백상홍/가톨릭의대 |
|
Dual Benefits by Lowering 2 Source of Atherogenic Cholesterol
|
김상현/서울의대 |